Arrowhead Pharmaceuticals (ARWR) Total Non-Current Liabilities (2011 - 2026)
Arrowhead Pharmaceuticals (ARWR) recorded Total Non-Current Liabilities of $1.36 billion in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 104.5% from $666.28 million a year earlier but down 0.8% from the prior quarter.
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Arrowhead Pharmaceuticals reported Total Non-Current Liabilities of $686.39 million, down 18.8% from FY2024.
- Annual Total Non-Current Liabilities has a five-year compound annual growth rate of 102.7% (FY2020 to FY2025).
- Across earlier fiscal years, Total Non-Current Liabilities came in at $845.57 million in FY2024 (+126.7%), $372.93 million in FY2023 (+176.8%), $134.75 million in FY2022 (-12.9%) and $154.79 million in FY2021 (+672.3%).
- Quarterly Total Non-Current Liabilities has ranged from $112.45 million in fiscal Q2 2022 to $1.37 billion in fiscal Q2 2026 over the past five years.
- On a year-over-year basis, Total Non-Current Liabilities rose in six of the last eight quarters, with growth averaging 67.3%.
- Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 672.3% in fiscal Q4 2021, against a decline of 21.9% in fiscal Q2 2022 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $1.37 billion (Q2 2026), $694.06 million (Q1 2026) and $686.39 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Arrowhead Pharmaceuticals | 9.35 Bn | 4.13 Bn | - | 1.36 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.36 Bn |
| Mar 31, 2026 | 1.37 Bn |
| Dec 31, 2025 | 694.06 Mn |
| Sep 30, 2025 | 686.39 Mn |
| Jun 30, 2025 | 666.28 Mn |
| Mar 31, 2025 | 668.73 Mn |
| Dec 31, 2024 | 863.86 Mn |
| Sep 30, 2024 | 845.57 Mn |
| Jun 30, 2024 | 448.07 Mn |
| Mar 31, 2024 | 394.57 Mn |
| Dec 31, 2023 | 388.85 Mn |
| Sep 30, 2023 | 372.93 Mn |
| Jun 30, 2023 | 343.64 Mn |
| Mar 31, 2023 | 339.05 Mn |
| Dec 31, 2022 | 373.11 Mn |
| Sep 30, 2022 | 134.75 Mn |
| Jun 30, 2022 | 149.39 Mn |
| Mar 31, 2022 | 112.45 Mn |
| Dec 31, 2021 | 128.95 Mn |
| Sep 30, 2021 | 154.79 Mn |
API Access
Arrowhead Pharmaceuticals Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();